A neuroanatomical and cognitive model of impaired social behaviour in frontotemporal dementia

A neuroanatomical and cognitive model of impaired social behaviour in frontotemporal dementia

A synergistic core for human brain evolution and cognition

APOEε4 carriership associates with microglial activation independently of Aβ plaques and tau tangles

Apathy as a Loss of Prior Precision on Action Outcomes

Behavioural changes in frontotemporal dementia and their cognitive and neuroanatomical correlates

Cellular signatures of functional resilience in presymptomatic frontotemporal dementia

Cerebrovascular reactivity impairment in genetic frontotemporal dementia

Characterization and super-resolution imaging of small tau aggregates in human samples

Clinical Recognition of Frontotemporal Dementia with Right Temporal Predominance; Consensus Recommendations of the International Working Group

Cognition’s dependence on functional network integrity with age is conditional on structural network integrity

Comparing and combining TSPO-PET tracers in tauopathies

Creating the Pick’s disease International Consortium: Association study ofMAPTH2 haplotype with risk of Pick’s disease

Dementia wellbeing and COVID-19: review and expert consensus on current research and knowledge gaps

Diagnostic and prognostic value of alpha-synuclein seed amplification assay in Parkinson’s disease: a longitudinal cohort study

Disentangling phonology from phonological short-term memory in Alzheimer’s disease phenotypes

Distinct components of cardiovascular health are linked with age-related differences in cognitive abilities

Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies

Dynamic targeting enables domain-general inhibitory control over action and thought by the prefrontal cortex

Executive function deficits in genetic frontotemporal dementia: results from the GENFI study

Frontoparietal network integrity supports cognitive function despite atrophy and hypoperfusion in pre-symptomatic frontotemporal dementia: multimodal analysis of brain function, structure and perfusion

Functional localization and categorization of intentional decisions in humans: a meta-analysis of brain imaging studies

GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degeneration

GABAergic regulation of action-outcome priors in conditions associated with frontotemporal degeneration

Genetic Semantic Dementia? Twins’ Data and Review of Autosomal Dominant Cases

Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study

Impaired semantic control in the logopenic variant of primary progressive aphasia

In vivo PET imaging of neuroinflammation in familial frontotemporal dementia

Inflammation PET and plasma neurofilament light predict survival in people with progressive supranuclear palsy

Lexical Markers of Disordered Speech in Primary Progressive Aphasia and ‘Parkinson-plus’ Disorders

Mapping the multidimensional geometric landscape of graded phenotypic variation and progression in neurodegenerative syndromes

Microglial activation and tau burden predict cognitive decline in Alzheimer’s Disease

Multidimensional cognitive deficits in the typical and atypical variants of Alzheimer’s disease

Multimodal fusion analysis of functional, cerebrovascular and structural neuroimaging in healthy ageing subjects

Neurochemistry-enriched dynamic causal models of magnetoencephalography, using magnetic resonance spectroscopy

Neurodevelopmental effects of genetic frontotemporal dementia mutations revealed by total intracranial volume differences

Neuroinflammation predicts disease progression in progressive supranuclear palsy

Neurophysiological and brain structural markers of cognitive frailty differs from Alzheimer’s disease

Neurophysiological consequences of synapse loss in progressive supranuclear palsy

Noradrenaline treatment of apathy and impulsivity in participants with Progressive Supranuclear Palsy syndromes

Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes

Noradrenergic modulation of saccades in Parkinson’s disease

Novel blood-based proteomic signatures across multiple neurodegenerative diseases

PULSE PRESSURE IMPAIRS COGNITION VIA WHITE MATTER DISRUPTION

Parkinson’s disease impairs cortical sensori-motor decision-making cascades

Peripheral inflammatory markers relate to central inflammation and survival in syndromes associated with frontotemporal lobar degeneration

Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival

Pharmacological and pupillary evidence for the noradrenergic contribution to reinforcement learning in Parkinson's disease

Post-Mortemvalidation ofin vivo18kDa Translocator Protein (TSPO) PET as a microglial biomarker

Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes

Reliability of dynamic causal modelling of resting state magnetoencephalography

Self-versus caregiver-reported apathy across neurological disorders

Small tau aggregates exhibit disease-specific molecular profiles across tauopathies

Social-semantic knowledge in frontotemporal dementia and after anterior temporal lobe resection

Substantia nigra ferric overload and neuromelanin loss in Parkinson’s disease measured with 7T MRI

Synaptic loss in behavioural variant frontotemporal dementia revealed by [11C]UCB-J PET

Tau accumulation patterns in PSP constrain mechanisms and quantify cell-to-cell and cell-autonomous aggregation rates

The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) longitudinal study protocol: Phase 4 (“Enrichment”) and Phase 5 (“Rescan”)

The Cambridge Questionnaire for Apathy and Impulsivity Traits (CamQUAIT): a novel assessment tool for frontotemporal lobar degeneration-related syndromes

The impact of bilateral versus unilateral anterior temporal lobe damage on face recognition, person knowledge and semantic memory

The social dimension of apathy: Evidence for a distinct domain from 11,243 individuals across health and neurocognitive disorders

Understanding how increasing some of the brain's chemicals can help thinking and behaviour in people with Parkinson’s disease

Understanding how increasing some of the brain's chemicals can help thinking and behaviour in people with frontotemporal dementia and progressive supranuclear palsy

Verbal fluency tests assess global cognitive status but have limited diagnostic differentiation: Evidence from a large-scale examination of six neurodegenerative diseases